Clinical Trial Update: Pancreatic Enzyme Suppletion in Pancreatic Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating pancreatic enzyme supplementation for pancreatic adenocarcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Foundation for Liver Research | Conditions: Adenocarcinoma of the Pancreas, Normal Pancreatic Exocrine Function | Phase 4 | Status: WITHDRAWN